{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neuroinflammatory+Response&page=2", "query": { "condition": "Neuroinflammatory Response", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neuroinflammatory+Response&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T19:48:54.749Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01440452", "title": "CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Inflammatory Myelopathies" ], "interventions": [ { "name": "FES Cycling", "type": "DEVICE" }, { "name": "Cycling without FES", "type": "DEVICE" }, { "name": "Lumbar puncture", "type": "PROCEDURE" }, { "name": "Mood assessment", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "PROCEDURE", "BEHAVIORAL" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 25, "start_date": "2010-11", "completion_date": "2019-07", "has_results": true, "last_update_posted_date": "2020-07-17", "last_synced_at": "2026-06-10T19:48:54.749Z", "location_count": 1, "location_summary": "Lutherville, Maryland", "locations": [ { "city": "Lutherville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01440452" }, { "nct_id": "NCT00856297", "title": "Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Meningitis" ], "interventions": [ { "name": "MenACWY-CRM conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "Licensed comparator", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "11 Years to 18 Years" }, "enrollment_count": 389, "start_date": "2009-02", "completion_date": "2012-11", "has_results": true, "last_update_posted_date": "2017-06-14", "last_synced_at": "2026-06-10T19:48:54.749Z", "location_count": 32, "location_summary": "Birmingham, Alabama • Fremont, California • Fresno, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fremont", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Hayward", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00856297" }, { "nct_id": "NCT00700713", "title": "Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis", "Meningococcemia" ], "interventions": [ { "name": "Meningococcal polysaccharide diphtheria toxoid conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "3 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "3 Years to 6 Years" }, "enrollment_count": 181, "start_date": "2008-06", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2016-02-15", "last_synced_at": "2026-06-10T19:48:54.749Z", "location_count": 13, "location_summary": "Marietta, Georgia • Woodstock, Georgia • Bardstown, Kentucky + 9 more", "locations": [ { "city": "Marietta", "state": "Georgia" }, { "city": "Woodstock", "state": "Georgia" }, { "city": "Bardstown", "state": "Kentucky" }, { "city": "Annapolis", "state": "Maryland" }, { "city": "Frederick", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00700713" }, { "nct_id": "NCT01431326", "title": "Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Adenovirus", "Anesthesia", "Anxiety", "Anxiolysis", "Autism", "Autistic Disorder", "Bacterial Meningitis", "Bacterial Septicemia", "Benzodiazepine", "Bipolar Disorder", "Bone and Joint Infections", "Central Nervous System Infections", "Convulsions", "Cytomegalovirus Retinitis", "Early-onset Schizophrenia Spectrum Disorders", "Epilepsy", "General Anesthesia", "Gynecologic Infections", "Herpes Simplex Virus", "Infantile Hemangioma", "Infection", "Inflammation", "Inflammatory Conditions", "Intra-abdominal Infections", "Lower Respiratory Tract Infections", "Migraines", "Pain", "Pneumonia", "Schizophrenia", "Sedation", "Seizures", "Skeletal Muscle Spasms", "Skin and Skin-structure Infections", "Treatment-resistant Schizophrenia", "Urinary Tract Infections", "Withdrawal", "Sepsis", "Gram-negative Infection", "Bradycardia", "Cardiac Arrest", "Cardiac Arrhythmia", "Staphylococcal Infections", "Nosocomial Pneumonia", "Neuromuscular Blockade", "Methicillin Resistant Staphylococcus Aureus", "Endocarditis", "Neutropenia", "Headache", "Fibrinolytic Bleeding", "Pulmonary Arterial Hypertension", "CMV Retinitis", "Hypertension", "Chronic Kidney Diseases", "Hyperaldosteronism", "Hypokalemia", "Heart Failure", "Hemophilia", "Heavy Menstrual Bleeding", "Insomnia" ], "interventions": [ { "name": "The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daniel Benjamin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 3520, "start_date": "2011-11", "completion_date": "2019-11", "has_results": false, "last_update_posted_date": "2023-09-06", "last_synced_at": "2026-06-10T19:48:54.749Z", "location_count": 43, "location_summary": "Anchorage, Alaska • Little Rock, Arkansas • La Jolla, California + 37 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01431326" }, { "nct_id": "NCT03604276", "title": "Neuroinflammatory Response and Headache Control in Patients After Subarachnoid Hemorrhage", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Subarachnoid Hemorrhage, Aneurysmal", "Headache", "Subarachnoid Hemorrhage" ], "interventions": [], "intervention_types": [], "sponsor": "MaineHealth", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2017-12-01", "completion_date": "2026-01-01", "has_results": false, "last_update_posted_date": "2024-01-09", "last_synced_at": "2026-06-10T19:48:54.749Z", "location_count": 1, "location_summary": "Portland, Maine", "locations": [ { "city": "Portland", "state": "Maine" } ], "official_url": "https://clinicaltrials.gov/study/NCT03604276" }, { "nct_id": "NCT00297817", "title": "Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningococcal Disease" ], "interventions": [ { "name": "serogroup B meningococcal vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "11 Years to 18 Years" }, "enrollment_count": 203, "start_date": "2006-02", "completion_date": "2007-04", "has_results": false, "last_update_posted_date": "2016-12-01", "last_synced_at": "2026-06-10T19:48:54.749Z", "location_count": 8, "location_summary": "Encinitas, California • Atlanta, Georgia • St Louis, Missouri + 5 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00297817" }, { "nct_id": "NCT05378659", "title": "Neuroinflammation and Alzheimer's Pathology in POCD", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Post-Operative Confusion", "Neuroinflammatory Response", "Alzheimer Disease" ], "interventions": [ { "name": "Montreal Cognitive Assessment", "type": "BEHAVIORAL" }, { "name": "Stroop Test", "type": "BEHAVIORAL" }, { "name": "4AT Delirium", "type": "DIAGNOSTIC_TEST" }, { "name": "Grooved Pegboard", "type": "BEHAVIORAL" }, { "name": "NACC Cognitive Battery", "type": "BEHAVIORAL" }, { "name": "ERP Testing", "type": "DIAGNOSTIC_TEST" }, { "name": "Blood Plasma and Serum sampling", "type": "DIAGNOSTIC_TEST" }, { "name": "Cerebral Spinal Fluid Sample", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "BEHAVIORAL", "DIAGNOSTIC_TEST" ], "sponsor": "University of Tennessee Graduate School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 120, "start_date": "2021-11-01", "completion_date": "2022-09-30", "has_results": false, "last_update_posted_date": "2022-05-18", "last_synced_at": "2026-06-10T19:48:54.749Z", "location_count": 1, "location_summary": "Knoxville, Tennessee", "locations": [ { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05378659" }, { "nct_id": "NCT00450437", "title": "A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Infections", "Meningococcal Meningitis" ], "interventions": [ { "name": "MenACWY CRM", "type": "BIOLOGICAL" }, { "name": "Meningococcal ACWY Conjugate vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "11 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "11 Years to 55 Years" }, "enrollment_count": 3539, "start_date": "2007-03", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2015-01-28", "last_synced_at": "2026-06-10T19:48:54.749Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Fremont, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Fremont", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Hayward", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00450437" }, { "nct_id": "NCT00012467", "title": "Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis, Cryptococcal", "HIV Infections" ], "interventions": [ { "name": "Itraconazole", "type": "DRUG" }, { "name": "Flucytosine", "type": "DRUG" }, { "name": "Fluconazole", "type": "DRUG" }, { "name": "Amphotericin B", "type": "DRUG" }, { "name": "Interferon gamma-1b", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "InterMune", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 60, "start_date": "2000-01", "completion_date": "2001-07", "has_results": false, "last_update_posted_date": "2009-06-03", "last_synced_at": "2026-06-10T19:48:54.749Z", "location_count": 7, "location_summary": "Birmingham, Alabama • St Louis, Missouri • Camden, New Jersey + 3 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Camden", "state": "New Jersey" }, { "city": "Newark", "state": "New Jersey" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00012467" }, { "nct_id": "NCT04636723", "title": "Neuroinflammation in Chronic Systemic Symptoms (CSS)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cancer", "Cancer Head Neck", "Neuroinflammatory Response", "Chronic Inflammation", "Chronic Disease", "Chronic Pain" ], "interventions": [], "intervention_types": [], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 30, "start_date": "2021-02-22", "completion_date": "2021-12-07", "has_results": false, "last_update_posted_date": "2023-01-26", "last_synced_at": "2026-06-10T19:48:54.749Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04636723" } ] }